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Introduction 
Amyloid-β (Aβ) fibrillization is described as a central event in the pathogenesis of 
Alzheimer’s disease (AD). Amyloid imaging is expected to play a pivotal role in early 
and differential diagnosis of dementias, and in the evaluation of anti-Aβ treatments. 
Luminescent conjugated oligothiophenes (LCO) have been proposed as optical 
biomarkers of protein fibrillation [1]. In this paper, we evaluated a fluorescent 
magnetic hybrid nanoprobe (HNP5011), based on gadolinium fluoride nanoparticles 
functionalized with luminescent conjugated polythiophenes moieties (Fig. 1). The aim 
of this study was to investigate its potential for molecular imaging in a rat model 
bearing intracerebral pre-aggregated Aβ peptides. 
 
Methods 
Recombinant human Aβ1-42 peptides were agitated at 200µM and 37°C. Resulting 
fibrils were characterized by transmission electron microscopy (TEM) and 
spectrofluorometry with thioflavine T (ThT). Rats were stereotaxically injected with 
5µl of fibrils on one hippocampus and with PBS on the contralateral side. Blood brain 
barrier (BBB) integrity was evaluated with magnetic resonance imaging (MRI) after 
gadolinium injection and with histology after Bleu Evans injection. Macrophage 
recruitment was highlighted on in vivo MRI and ex vivo Synchrotron Radiation X-ray 
phase contrast CT (SR-PCT) after ultrasmall superparamagnetic iron oxide injection. 
The capacity of HNP5011 to detect amyloid fibrils was investigated after stereotaxic 
(140µM, 2.5µl) or intravenous (14mM, 75µmol Gd/kg) injection of the nanoparticles. 
Brain sections were used for fluorescence microscopy. 
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Results 
Pre-aggregated Aβ peptide injection caused transient BBB disruption and 
macrophage recruitment as well as few complications such as petechial hemorrhage 
and inflammatory oedema around the injection site. HNP5011 was visible on MRI 
and SR-PCT after stereotaxic injection (Fig. 2) but not visible after intravenous 
injection. Post-mortem fluorescence on brain tissue without MRI detection could also 
be explained by in vivo dissociation of HNP5011.  
 
Conclusion 
This preliminary evaluation highlighted the need to bring the HNP5011 solution at a 
higher concentration to reach MRI detection threshold after intravenous injection. 
Biostability of the nanoparticle deserves further studies.  
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Figures 
 
 
 
Figure 1. Hybrid nanoparticle 5011.  
 
 
 
 
 
 
 
 
Figure 2. Back-to-back MRI and SR-PCT detection of intra-cerebral hybrid 
nanoparticle 5011 injected in right (red) and left (blue) hippocampi after stereotaxic 
injection of pre-aggregated amyloid fibrils (in left hippocampus only).  
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